Author: Maria Bzówka; Karolina Mitusinska; Agata Raczynska; Aleksandra Samol; Jack Tuszynski; Artur Góra
Title: Molecular Dynamics Simulations Indicate the SARS-CoV-2 Mpro Is Not a Viable Target for Small-Molecule Inhibitors Design Document date: 2020_3_2
ID: mp3a9c9u_21
Snippet: The analysis of the water hot-spots shows that the catalytic water hot-spot dominates water distribution inside the binding cavity. The remaining water hot-spots correspond to a much lower water density level and are on the borders of the binding cavity, which suggests a rather hydrophobic or neutral interior of the binding cavity. The MixMD simulations performed with various cosolvents have further confirmed these observations. The largest numbe.....
Document: The analysis of the water hot-spots shows that the catalytic water hot-spot dominates water distribution inside the binding cavity. The remaining water hot-spots correspond to a much lower water density level and are on the borders of the binding cavity, which suggests a rather hydrophobic or neutral interior of the binding cavity. The MixMD simulations performed with various cosolvents have further confirmed these observations. The largest number and the densest hot-spots were located within the binding cavity and the region essential for Mpros dimerisation [31] , between the II and III domains. The deep insight into the local hot-spots distribution of the various cosolvents underlines the large differences in binding sites plasticity. The smaller binding cavity of the SARS-CoV-2 enlarged significantly in the presence of a highly hydrophobic cosolvent. The benzene hot-spots were detected deep inside the cavity, and also near the C44-P52 loop. In contrast, in the case of the SARS-CoV, benzene hot-spots were located only in the vicinity of the C44-P52 loop. Such a conclusion may also imply that a sufficiently potent inhibitor of SARS-CoV and/or SARS-CoV-2 Mpros needs to be able to open its way to the active site before it can successfully bind to its cavity. These results support the regulatory role of the C44-P52 loop and again alert against unwarranted use of simplified approaches for drug repositioning or docking.
Search related documents:
Co phrase search for related documents- active site and bind site: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- active site and cavity bind: 1
- active site and hot spot: 1
- active site and III II domain: 1
- active site and large difference: 1
- active site and large number: 1, 2, 3, 4, 5
- active site and loop vicinity: 1
- active site and regulatory role: 1, 2, 3
- active site and SARS CoV case: 1
Co phrase search for related documents, hyperlinks ordered by date